1. Home
  2. GRFS vs IRTC Comparison

GRFS vs IRTC Comparison

Compare GRFS & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • IRTC
  • Stock Information
  • Founded
  • GRFS 1940
  • IRTC 2006
  • Country
  • GRFS Spain
  • IRTC United States
  • Employees
  • GRFS N/A
  • IRTC N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • IRTC Medical/Dental Instruments
  • Sector
  • GRFS Health Care
  • IRTC Health Care
  • Exchange
  • GRFS Nasdaq
  • IRTC Nasdaq
  • Market Cap
  • GRFS 6.6B
  • IRTC 5.8B
  • IPO Year
  • GRFS 2006
  • IRTC 2016
  • Fundamental
  • Price
  • GRFS $9.61
  • IRTC $177.54
  • Analyst Decision
  • GRFS Hold
  • IRTC Strong Buy
  • Analyst Count
  • GRFS 1
  • IRTC 12
  • Target Price
  • GRFS $10.30
  • IRTC $173.17
  • AVG Volume (30 Days)
  • GRFS 550.4K
  • IRTC 352.9K
  • Earning Date
  • GRFS 01-01-0001
  • IRTC 10-29-2025
  • Dividend Yield
  • GRFS 1.47%
  • IRTC N/A
  • EPS Growth
  • GRFS 132.60
  • IRTC N/A
  • EPS
  • GRFS 0.53
  • IRTC N/A
  • Revenue
  • GRFS $8,744,226,659.00
  • IRTC $657,227,000.00
  • Revenue This Year
  • GRFS $5.61
  • IRTC $25.17
  • Revenue Next Year
  • GRFS $6.70
  • IRTC $16.97
  • P/E Ratio
  • GRFS $24.41
  • IRTC N/A
  • Revenue Growth
  • GRFS 9.32
  • IRTC 22.37
  • 52 Week Low
  • GRFS $6.19
  • IRTC $55.92
  • 52 Week High
  • GRFS $11.14
  • IRTC $187.57
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 41.63
  • IRTC 57.33
  • Support Level
  • GRFS $9.56
  • IRTC $158.02
  • Resistance Level
  • GRFS $10.23
  • IRTC $174.21
  • Average True Range (ATR)
  • GRFS 0.18
  • IRTC 6.30
  • MACD
  • GRFS -0.01
  • IRTC -0.59
  • Stochastic Oscillator
  • GRFS 11.85
  • IRTC 69.40

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About IRTC iRhythm Technologies Inc.

iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Share on Social Networks: